CD27 Stimulation Unveils the Efficacy of Linked Class I/Ii Peptide Vaccines in Poorly Immunogenic Tumors by Orchestrating a Coordinated CD4/CD8 T Cell Response
OncoImmunology - United States
doi 10.1080/2162402x.2018.1502904
Full Text
Open PDFAbstract
Available in full text
Date
September 5, 2018
Authors
Publisher
Informa UK Limited